Physician profile
Gregory M Neely
NPI 1912027608
$25,781.53
in general payments reported to CMS, 2019-2025
15 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,250 · 2020: $3,357 · 2021: $18K · 2022: $396 · 2023: $155 · 2024: $18.07 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $18,653.95 | 2019-2021 | |
| Arthrex, INC. | $4,497.71 | 2019-2023 | |
| Conetic Solutions, INC. | $920.53 | 2020 | |
| Rsw Medical Company, INC. | $635.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $376.48 | 2022-2025 | Persona |
| Stryker Corporation | $278.35 | 2019-2025 | Infinity Adaptis |
| Bioventus LLC | $169.44 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Exactech, INC. | $124.14 | 2023 | |
| Abbott Laboratories | $38.85 | 2025 | Proclaim |
| Paragon 28, INC. | $26.83 | 2020 | |
| Pacira Therapeutics, INC. | $17.42 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.73 | 2019 | |
| Convatec INC. | $13.09 | 2019 | |
| Merck Sharp & Dohme LLC | $11.98 | 2019 | |
| Kinex Medical Company LLC | $3.73 | 2024 | Kinex Kck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Neely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.